New qtr and new year. Lots of interest in INSM in the biotech space. They may quickly get this $20 so they can get more shares (from retail sellers) and then will take it to $30 plus before 1Q end.
I Don't see INSM being bought by a larger pharma for another year or two. There will be a lot of interest though.
I think you a loadup.Insti2tions buy last yrs big.Be happy notstupid